ReviewPaediatric & neonatal pain2021
Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period.
Review in Paediatric & neonatal pain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Fascia iliaca compartment block for surgical analgesia in children with osteogenesis imperfecta: A retrospective cohort study.PloS one · 2026Article
- Article
- Case Report: Holistic approach to management of an infant with severe osteogenesis imperfecta in the neonatal intensive care unit.Frontiers in pediatrics · 2025Article
- Respiratory insufficiency in an infant with osteogenesis imperfecta.Respiratory medicine case reports · 2024Article
- Early Life Management of Osteogenesis Imperfecta.Current osteoporosis reports · 2023Review
- Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period.Paediatric & neonatal pain · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
Osteogenesis imperfecta (OI) is a rare genetic heterogeneous disorder that causes increased bone fragility and recurrent fractures. For infants with OI and diffuse fractures, pain management, which is nuanced and specific for this population, is of the utmost importance to their neonatal care. Through experience at our center, we have developed a standard approach that has been successful in optimizing survival for these infants during this tenuous period. In this paper, we outline our multidisciplinary approach to pain management for infants with moderate to severe OI during the neonatal period, with emphasis on promotion of fracture healing and adequate pain control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.